---
title: "An Epigenetic Study of Treatment Effects and Environmental Factors in Schizophrenia and Bipolar Disorder"
subtitle: "Monthly FoU Meeting &#x1F337; <br/>"  
author: 
  - "Jonelle Villar - PhD Candidate"
date: "April 4, 2024"
output:
  xaringan::moon_reader:
    css: [xaringan-themer.css, yellow_dots.css, extra.css]
    nature:
      slideNumberFormat: "%current%"
      highlightStyle: github
      highlightLines: true
      ratio: 16:9
      countIncrementalSlides: true
      
---

```{r setup, include=FALSE}
options(htmltools.dir.version = FALSE)
knitr::opts_chunk$set(
  fig.width=9, fig.height=3.5, fig.retina=3,
  out.width = "100%",
  cache = FALSE,
  echo = TRUE,
  message = FALSE, 
  warning = FALSE,
  hiline = TRUE
)

library(fontawesome)
library(tidyverse)
library(xaringan)
library(here)



```

```{r xaringan-themer, include=FALSE, warning=FALSE}
library(xaringanthemer)

dark_yellow <- "#EFBE43"
light_yellow <- "#FDF7E9"
gray <- "#333333"
blue <- "#4466B0"

style_duo(
  # colors
  primary_color = light_yellow,
  secondary_color = dark_yellow,
  header_color = gray,
  text_color = gray,
  code_inline_color = colorspace::lighten(gray),
  text_bold_color = colorspace::lighten(gray),
  link_color = blue,
  title_slide_text_color = blue,

  # fonts
  header_font_google = google_font("Martel", "300", "400"),
  text_font_google = google_font("Lato"),
  code_font_google = google_font("Fira Mono")  
)



```

```{r xaringanExtra, echo=FALSE, warning=FALSE}

library(xaringanExtra)
xaringanExtra::use_logo("slides/UiBlogoMED_gray_v_Eng.png",
                        width = "250px",
                        height = "250px",
                        position = xaringanExtra::css_position(top = "2em", right = "2em"))
                     

xaringanExtra::use_tile_view()

```


```{css extra.css, echo=FALSE}

.small { 
  font-size: 0.75em
}  

.bitty { 
    font-size: 1.25em;
}

.enlarge { 
    font-size: 1.5em;
}

.fade {
  opacity: 0.66;
}

```

---

background-image: url(slides/Kelly1.png)
background-position:75% 70%
background-size: 650px

class: top left
##Ett P√•sken√∏tt 
.enlarge["Astronaut Scott Kelly had altered gene after one year in space, <br> but not his twin on earth."]

.footnote[The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight, Science, 2019]

---
class: hide_logo

background-image: url(slides/Smigielski.png)
background-position:cover
background-size: 700px

.footnote[Smigielski, _et al_, Molecular Psychiatry, 2020]

---


class: top left
### **DNA methylation** <br> <br />

.pull-left[

![molecule](slides/chemMol.jpeg)
] 

.pull-right[

![histones](slides/dna-methylation-histones.jpeg)
] 

---
background-image: url(slides/cellsformat.png)
background-position:50% 65%
background-size: 750px

class: top, left
### DNA derived from leukocytes

---

###General aim of this PhD work
.enlarge[
 - To identify epigenetic marks (CpGs) associated with psychosis and treatment effects. <br />
]

###Specific questions
.bitty[
- Does **time-of-blood draw** impact the association of SCZ vs controls on cell-type proportions? <br> <br />
- What common and specific CpGs are seen following **antipsychotic** drug treatment for psychosis? <br> <br />

]  

---
###Project 1
 .enlarge[Does **time-of-blood draw** impact the association of SCZ vs controls on cell-type proportions?

* Background <br><br />
  - SCZ is associated with altered cell-type proportions (Hannon _et al._, 2021) <br><br />
    - Immune cell alterations (NLR); age, gender, smoking, medication <br><br />
    - Disrupted diurnal (circadian) rhythms 
  ]
---
background-image: url(slides/diurnal_seasonal4.png)
background-position:50% 75%
background-size: 700px


class: left top
### Diurnal and seasonal cellular fluctuations 


.footnote[adapted: Oh _et al._, Geonome Biology, 2019; Wyse _et al._ iScience, 2021]

---
###Circadian rhythms and "chrono-epigenetics" <br> <br> 

.bitty[
- Morning light strong activator of clock genes and physiological processes <br> <br>
- Circadian clock genes co-evolved with the methyl cycle (Fustin, _et al._, 2020) <br> <br>
- Chrono-epigenetics: <br> <br>
    - temporal dynamics of epigenetic processes <br> <br>
    - oscillating CpGs contribute to epigenetic variability (Oh, E. & Petronis, 2021)
]

---

class: top left 
### Oscillating CpGs
.center[<img src=slides/osc_modC.gif width="40%">]


---

background-image: url(slides/Oh2019cc.png)
background-position:60% 35%
background-size: 725px

class: left top
### **Epigenetic oscillations**<br><br> <br> <br> <br> <br>

.bitty[
* Gray boxes - "office hours"
* Black curves - oscillation profiles
* Red dots - randomly selected blood-draw time 

]


.footnote[Fig.adapted: Oh _et al._, Genome Biology, 2019]


---

###Method of analysis 

.bitty[
1. Selected European SCZ cases & controls with recorded time-of-blood draw (n=729) <br> <br>
1. Calculated variable ‚Äúhours from 07:00 baseline‚Äù <br> <br>
1. Samples matched for age and sex <br> <br>
1. Compared full day vs half day <br> <br>
1. Sub-analysis: Neutrophil-to-lymphocyte ratio (NLR) <br> <br>
1. Sub-analysis: Medication-free SCZ cases
]

---

background-image: url(slides/2021_08_05_Histogram_n729.png)
background-position: 50% 45% 
background-size: 425px

class: left, top
###Distribution of recorded blood draws (n=729) <br> <br> <br> <br> <br> <br> <br> <br /> 


- __Model 1: Cell-type proportions ~  Case_Control + Age + Sex + Smoking_score + Methbatch + ùú∫__
- __Model 2: Cell-type proportions ~ Case_Control + Age + Sex + Smoking_score + Methbatch + Hours_from_baseline + ùú∫__

---
background-image: url(slides/2021_09_04_Table.CorrectPvalsTeal.png)
background-position: 25% 45% 
background-size: 400px

class: top left 
###Results

.pull-right[

.enlarge[__Full day (n=729)__]

.bitty[
- P-values reduced significance in Model 2
- Effect sizes diminished in Model 2
]

.enlarge[__Half day (n=524)__]

.bitty[
- P-values: no significant change 
- Effect sizes: no change
]
]

---
class: top left hide_logo
###Results Sub-analyses 

.enlarge[
* __NLR__: significant association SCZ vs controls in all analyses (_p_ <.001) <br> <br>
* __Medication-free cases__: significant association SCZ vs controls for neutrophils & CD4T both models (_p_ <.01)

###Conclusion Project 1:

To reduce epigenetic variation associated with time-of-blood draw and the circadian cycling of white blood cells
* either correct for __cell-types__ - or for __time-of-blood draw__
]

---
###Project 2 <br> <br /> 
 .enlarge[What common and specific CpGs are seen following **antipsychotic** treatment for psychosis?]


---

background-image: url(slides/clinical_course.png)
background-position: 50% 75% 
background-size: 750px

class: top left 

### Background - Psychosis
.enlarge[Symptoms:
* Hallucinations, delusions, social withdrawal and apathy
* **Loss of insight** into their condition] 

.footnote[McCutcheon, _et al._, JAMA Psychiatry, 2020; Elanjithara, _et al._, Advances in Psych Treatment, 2011]

---
class: top left 

### Background - Antipsychotics
.enlarge[Antipsychotics (AP) first line of treatment 
* Dopamine dysregulation &#x02192; psychosis and mechanism of AP action <br> <br />
* 1st generation AP: dopamine receptor antagonists <br> <br />
* 2nd generation AP: dopamine and serotonin receptor antagonists <br> <br />
* Different dopamine binding affinities and profiles <br> <br />
* Side-effect profile: weight gain, sedation, glucose and lipid metabolism disturbances 
]
    
.footnote[Kaar _et al._, Neuropharmacology, 2020]        
---

background-image: url(slides/Aringhieri2.jpg)
background-position: 60% 75%
background-size: 775px

class: left, top

###Molecular targets

.footnote[Aringhieri _et al_, Pharmacology & Therapeutics, 2018]

---

### EWAS findings and status  
 .enlarge[Genes:_DRD2_, _DRD3_, _HTR2A_, _SLC6A4_, _COMT_] <br> <br />
 
.bitty[__Challenges__:
* Variety of methods, tissues assayed, study designs, sample sizes <br> <br /> 
* No uniform identification/reporting of hyper- or hypo-methylation  <br> <br>
* Lack of consistency in reporting medication <br> <br /> 
* Studies of AP monotherapy are lacking  <br> <br>
* Studies of AP serum values associated with DNAm are lacking.
 
]

.footnote[Burghardt _et.al_, Pharmacotherapy, 2020; Zhang & Malhotra, Current Psychiatry Reports, 2018]

---
class: top left
###Method of analysis 

.bitty[**To identify specific effects**: 
1. Select European SCZ & BPD cases - AP monotherapy with positive serum values (n=433) <br> <br>
 - Aripiprazole (n = 62)
 - Olanzapine   (n = 192)
 - Quetiapine   (n = 122)  
 - Risperdal    (n = 57) <br> <br>
1. No need to correct for time-of-blood draw as these are all cases <br> <br>
1. Model: DNAm ~ AP_serum_value + OtherMeds + Age + Sex + Smoking_score + Cells +ùú∫<br> <br>
1. Identify CpGs, associated genes, and differentially methylated regions (DMRs) <br> <br>
1. Gene set enrichment and pathway analysis  
]

---

class:top left

### Model selected for Quetiapine  <br><br>
* .enlarge[Serum values > 0, n = 92] <br><br> <br>

.enlarge[DNAm ~ Serum1 + Serum2 + Serum_Lithium + Age + Sex + SmokingScore + Cells +ùú∫]  

---
background-image: url(slides/Que_n92_Mod1_manhatt.png)
background-position: 75% 75%
background-size: 500px


class: top left
### Preliminary results: <br> 

.enlarge[**GLT8D1: Glycosyltransferase 8 Domain Containing 1**]

.pull-left[.enlarge[CpG: Pval = 2.25e-08 <br> <br>
adj BH Pval = 0.017 ]
]

---
background-image: url(slides/Mealer_glyco.jpg)
background-position: 20% 75%
background-size: 325px

class: left top 

### Dysregulated glycosylation in SCZ 

.pull-right[.enlarge[
GluA1,***GRIA1***: glutamate; cell-surface expression <br> <br /> 
GluN2A,***GRIN2A***: glutamate; receptor localization <br> <br />
CaV1.2,***CACNA1C***: calcium;cell-surface expression <br> <br />
DR2,***DRD2***: dopamine;cell-surface expression
]
]

.pull-right[.footnote[Mealer _et al_, Molecular Psychiatry, 2020]]


---
class: top left
### Further steps <br> <br />

.enlarge[
* Specific effects: Continue analyses with other mono therapies<br> <br />
* Common effects: Compare antipsychotic therapy vs non antipsychotic use
]

---

background-image: url(slides/Martens2.jpg)
background-position: 12% 60%, 20% 10%
background-size: 600px

class: top center hide_logo

# Acknowledgements

.pull-right[
**Supervisor Prof. St√©phanie Le Hellard**<br><br>
**Co-Supervisor Dr. Anne-Kristin Stavrum**<br><br>
**Colleagues in The Martens Group**<br><br>
**Dept. of Clinical Science II** <br><br><br>
**NORMENT** <br><br><br>
]

---
class: top center hide_logo

background-image: url(slides/red_egg2.png)
background-position: 50% 75%
background-size: 375px

###God P√•ske til alle!













